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A corrigendum on
G-CSF does not influence C2C12 myogenesis despite receptor expression in healthy and
dystrophic skeletal muscle
byWright, C. R., Brown, E. L., Della-Gatta, P. A., Ward, A. C., Lynch, G. S., and Russell, A. P. (2014).
Front. Physiol. 5:170. doi: 10.3389/fphys.2014.00170
In the original article, there was a mistake in Figure 1. Identification of G-CSFR in human and
rodent skeletal muscle, as published. The mistake is found in part 1A of the figure which should
show that PCR product frommouse tissues (left hand image) and human tissues (right hand image).
Unfortunately, when preparing the image the right hand agarose gel image that was embedded is the
same as the left hand image. The corrected Figure 1 and figure legend appears below. The authors
apologize for this error and state that this does not change the scientific conclusions of the article
in any way.
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FIGURE 1 | Identification of G-CSFR in rodent and human skeletal muscle. (A) cDNA fragment amplified during Real Time-PCR using the primers described in
Table 1, separated on a 1.8% Sybr safe (Invitrogen) agarose gel and exposed to UV light. (B) Western blot image identifying G-CSFR in rodent and human skeletal
muscle in vitro and ex vivo. (C) Western blot for G-CSFR in positive (BAF/3[G]) and negative (293T) control cells. (D) G-CSFR after deglycosylation with PGNase. C2B
(C2C12 myoblasts), C2T (C2C12 myotubes), Dia (diaphragm muscle from C57BLK mice), TA (tibialis anterior muscle from C57BLK mice), HpB (human primary
myoblasts), HpT (human primary myotubes) HVL (human vastus lateralis muscle), BAF/3[G] (murine pro B cell line overexpressing G-CSFR), 293T (human embryonic
kidney 293T cell line), 1kb+ [1 kb plus ladder (Invitrogen) and WB (Whole blood (human)].
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